Related stories
Wendy’s Rejects $1.4 Billion Buyout Bid, Adopts Poison Pill
Wendy’s rejected a $1.4 billion buyout offer from an activist investor and adopted a poison pill plan.
M impact | MNA | Nov 05, 2026, 02:05 PM UTC
Azimut Expects FSI Authorization Filing for Fintech Bank Transaction
Azimut said FSI is expected to file an authorization request with the Bank of Italy to proceed with a transaction intended to create a new fintech bank. The supplied report says th
L impact | MNA | Nov 05, 2026, 01:57 PM UTC
Qyuns Therapeutics Licenses Antibody Program to Caldera
Qyuns Therapeutics said it is licensing an early-stage antibody program to US biotech Caldera Therapeutics in a deal worth up to $750 million plus an upfront fee.
M impact | MNA | Nov 05, 2026, 01:56 PM UTC
BHAV Acquisition Agreement Values Nemi at $400M Pre-Money
The business combination agreement sets Nemi's pre-money equity value at $400 million, or 40 million shares at $10 per share.
M impact | MNA | Nov 05, 2026, 01:48 PM UTC
Forge Nano Completes HZO Acquisition in All-Stock Deal
Forge Nano completed its acquisition of HZO in an all-stock deal, combining atomic-scale deposition technology with high-volume protective coating capabilities.
M impact | MNA | Nov 05, 2026, 01:35 PM UTC
Mufin Green Finance Approves 23% Bimapay Finsure Stake Purchase
Mufin Green Finance approved the acquisition of a 23% equity stake in Bimapay Finsure for 657.5 million rupees.
M impact | MNA | Nov 05, 2026, 01:14 PM UTC